세계의 희소 바이오마커 검체 수집 및 안정화 시장 보고서(2025년)

Rare biomarkers specimen collection and stabilization involves the process of gathering and preserving biological samples that contain rare or low-abundance molecules, which indicate specific biological processes, diseases, or conditions. These biomarkers can include specific proteins, nucleic acids, metabolites, or other substances. The goal of collecting and preserving these rare biomarkers is to allow for accurate and reliable measurement and analysis for diagnostic, prognostic, and therapeutic purposes.

The primary types of rare biomarker specimen collection and stabilization include circulating cell-free DNA (ccFDNA), circulating tumor cells (CTCs), exosomes, and extracellular vesicles. Circulating cell-free DNA (ccFDNA) consists of DNA fragments freely circulating in the bloodstream, originating from both healthy and diseased cells. These fragments carry genetic information and can be analyzed for various diagnostic purposes, such as cancer detection or monitoring treatment effectiveness. Various specimens, such as serum or plasma, are used for applications including non-invasive prenatal testing (NIPT), oncology, transcriptomics, pharmacogenomics, transplant rejection, population screening, cardiovascular diseases, and others. These specimens are utilized by a range of end-users, including hospitals, perinatal clinics, public health labs, private or commercial labs, physician labs, research institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The rare biomarkers specimen collection and stabilization market research report is one of a series of new reports from The Business Research Company that provides rare biomarkers specimen collection and stabilization market statistics, including the rare biomarkers specimen collection and stabilization industry global market size, regional shares, competitors with rare biomarkers specimen collection and stabilization market share, detailed rare biomarkers specimen collection and stabilization market segments, market trends, and opportunities, and any further data you may need to thrive in the rare biomarkers specimen collection and stabilization industry. These rare biomarkers specimen collection and stabilization market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The rare biomarkers specimen collection and stabilization market size has grown rapidly in recent years. It will grow from $32.01 billion in 2024 to $35.29 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the human genome project, increase in cancer research, pharmaceutical R&D investment, growth of genomics and proteomics, and improved data management and bioinformatics.

The rare biomarkers specimen collection and stabilization market size is expected to see strong growth in the next few years. It will grow to $51.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the expansion of liquid biopsy applications, consumer awareness and demand, increasing adoption of non-invasive techniques, and biomarker discovery in rare diseases. Major trends in the forecast period include advancements in preservation technology, growth in genomic and proteomic research, the emergence of point-of-care testing, and regulatory advancements and standardization, enhanced data analytics, and AI integration.

The forecast of 9.8% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. labs by restricting access to cryopreservation tubes and stabilizing reagents imported from Denmark and China, potentially compromising rare disease research and increasing biobanking costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is expected to propel the growth of the rare biomarker specimen collection and stabilization market. Cancer, characterized by the uncontrolled proliferation and spread of abnormal cells, is rising in prevalence due to environmental pollutants and lifestyle factors, such as smoking and poor diet choices, which exacerbate genetic predispositions. The utilization of rare biomarker specimen collection and stabilization methods in cancer prevalence studies facilitates more accurate detection and monitoring of specific cancer types, thereby enhancing diagnostic and therapeutic approaches. For example, in October 2023, a report by the European Commission, a Europe-based governing body, indicated that new cancer cases rose to 2.74 million in 2022, reflecting a 2.3% increase from 2020. Consequently, the increasing prevalence of cancer is driving the growth of the rare biomarker specimen collection and stabilization market.

Major companies in the rare biomarker specimen collection and stabilization market are focusing on developing innovative solutions, such as pre-analytical platforms to automate the preparation of plasma and cell samples for multiomic liquid biopsy. Pre-analytical platforms provide consistent, automated fresh sample preparation at the time of blood collection, allowing for complete walk-away processing of whole blood without the need for special tubes or skilled professionals, thus preserving sample integrity. For instance, in May 2022, Tethis S.p.A., an Italy-based biotechnology company, launched See.d, the first fully automated, standardized pre-analytical platform offering unique features such as precise sample handling, efficient separation of plasma for cellular fractions, and fixation of white blood cells on SmartBioSurface slides. The platform includes a quality control scoring system for objectively evaluating sample stability, enabling the systematic scoring of proteomics and metabolomics data sets to determine the stability of plasma and serum samples.

In October 2022, DiaSorin, an Italy-based biotechnology company, acquired Luminex Corporation for an undisclosed amount. With this acquisition, DiaSorin aims to leverage multiplexing technology and Luminex's portfolio to strengthen its existing offerings. This acquisition aims to enhance DiaSorin's diagnostic testing capabilities, expand its market presence, and drive innovation in the molecular and immunodiagnostics sectors. Luminex Corporation is a US-based provider of proprietary biological testing instruments involving rare biomarker specimen collection and stabilization.

Major companies operating in the rare biomarkers specimen collection and stabilization market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Miltenyi Biotec GmbH, Natera Inc., Promega Corporation, Myriad Genetics, Hamilton Company, OraSure Technologies Inc., Fluidigm Corporation, Streck Inc., SeraCare, Enzo Biochem Inc., Epigenomics AG, Veridex LLC

North America was the largest region in the rare biomarkers specimen collection and stabilization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare biomarkers specimen collection and stabilization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rare biomarkers specimen collection and stabilization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The rare biomarkers specimen collection and stabilization market consists of revenues earned by entities by providing services such as sample collection, stabilization and preservation, customized collection protocols, bio banking and storage and data management and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The rare biomarkers specimen collection and stabilization market also includes sales of biomarker collection kits, laboratory equipment, training and educational materials, quality control materials, and sample storage containers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rare Biomarkers Specimen Collection And Stabilization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rare biomarkers specimen collection and stabilization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rare biomarkers specimen collection and stabilization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare biomarkers specimen collection and stabilization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Circulating Cell Free Deoxyribonucleic Acid (CCFDNA); Circulating Tumor Cells (CTCs); Exosomes or Extracellular Vesicles
• 2) By Specimen: Serum Or Plasma; Other Specimens
• 3) By Application: Non-Invasive Prenatal Testing (NIPT); Oncology; Transcriptomics; Pharmacogenomics; Transplant Rejection; Population Screening; Cardiovascular Diseases; Other Applications
• 4) By End-User: Hospitals; Perinatal Clinics; Public Health Labs; Private Or Commercial Labs; Physician Labs; Research Institutes; Other End-Users
• Subsegments:
• 1) By Circulating Cell Free Deoxyribonucleic Acid (CCFDNA): Plasma CCFDNA; Serum CCFDNA
• 2) By Circulating Tumor Cells (CTCs): CTCs In Blood; CTCs In Bone Marrow
• 3) By Exosomes Or Extracellular Vesicles: Exosomes From Plasma; Exosomes From Serum
• Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Becton Dickinson and Company; Eurofins Scientific SE; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Charles River Laboratories International Inc.; Bio-Rad Laboratories Inc.; Bruker Corporation; QIAGEN N.V.; Miltenyi Biotec GmbH; Natera Inc.; Promega Corporation; Myriad Genetics; Hamilton Company; OraSure Technologies Inc.; Fluidigm Corporation; Streck Inc.; SeraCare; Enzo Biochem Inc.; Epigenomics AG; Veridex LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rare Biomarkers Specimen Collection And Stabilization Market Characteristics

3. Rare Biomarkers Specimen Collection And Stabilization Market Trends And Strategies

4. Rare Biomarkers Specimen Collection And Stabilization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Rare Biomarkers Specimen Collection And Stabilization Growth Analysis And Strategic Analysis Framework

• 5.1. Global Rare Biomarkers Specimen Collection And Stabilization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Rare Biomarkers Specimen Collection And Stabilization Market Growth Rate Analysis
• 5.4. Global Rare Biomarkers Specimen Collection And Stabilization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Rare Biomarkers Specimen Collection And Stabilization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Rare Biomarkers Specimen Collection And Stabilization Total Addressable Market (TAM)

6. Rare Biomarkers Specimen Collection And Stabilization Market Segmentation

• 6.1. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Circulating Cell Free Deoxyribonucleic Acid (CCFDNA)
• Circulating Tumor Cells (CTCs)
• Exosomes Or Extracellular Vesicles
• 6.2. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Or Plasma
• Other Specimens
• 6.3. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive Prenatal Testing (NIPT)
• Oncology
• Transcriptomics
• Pharmacogenomics
• Transplant Rejection
• Population Screening
• Cardiovascular Diseases
• Other Applications
• 6.4. Global Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Perinatal Clinics
• Public Health Labs
• Private Or Commercial Labs
• Physician Labs
• Research Institutes
• Other End-Users
• 6.5. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Cell Free Deoxyribonucleic Acid (CCFDNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasma CCFDNA
• Serum CCFDNA
• 6.6. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Circulating Tumor Cells (CTCs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CTCs In Blood
• CTCs In Bone Marrow
• 6.7. Global Rare Biomarkers Specimen Collection And Stabilization Market, Sub-Segmentation Of Exosomes or Extracellular Vesicles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exosomes From Plasma
• Exosomes From Serum

7. Rare Biomarkers Specimen Collection And Stabilization Market Regional And Country Analysis

• 7.1. Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Rare Biomarkers Specimen Collection And Stabilization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market

• 8.1. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rare Biomarkers Specimen Collection And Stabilization Market

• 9.1. China Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 9.2. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rare Biomarkers Specimen Collection And Stabilization Market

• 10.1. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rare Biomarkers Specimen Collection And Stabilization Market

• 11.1. Japan Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 11.2. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rare Biomarkers Specimen Collection And Stabilization Market

• 12.1. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market

• 13.1. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rare Biomarkers Specimen Collection And Stabilization Market

• 14.1. South Korea Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 14.2. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market

• 15.1. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 15.2. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rare Biomarkers Specimen Collection And Stabilization Market

• 16.1. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rare Biomarkers Specimen Collection And Stabilization Market

• 17.1. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rare Biomarkers Specimen Collection And Stabilization Market

• 18.1. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rare Biomarkers Specimen Collection And Stabilization Market

• 19.1. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rare Biomarkers Specimen Collection And Stabilization Market

• 20.1. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market

• 21.1. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 21.2. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rare Biomarkers Specimen Collection And Stabilization Market

• 22.1. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rare Biomarkers Specimen Collection And Stabilization Market

• 23.1. North America Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 23.2. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rare Biomarkers Specimen Collection And Stabilization Market

• 24.1. USA Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 24.2. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rare Biomarkers Specimen Collection And Stabilization Market

• 25.1. Canada Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 25.2. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rare Biomarkers Specimen Collection And Stabilization Market

• 26.1. South America Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 26.2. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rare Biomarkers Specimen Collection And Stabilization Market

• 27.1. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rare Biomarkers Specimen Collection And Stabilization Market

• 28.1. Middle East Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 28.2. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rare Biomarkers Specimen Collection And Stabilization Market

• 29.1. Africa Rare Biomarkers Specimen Collection And Stabilization Market Overview
• 29.2. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Specimen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Rare Biomarkers Specimen Collection And Stabilization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rare Biomarkers Specimen Collection And Stabilization Market Competitive Landscape And Company Profiles

• 30.1. Rare Biomarkers Specimen Collection And Stabilization Market Competitive Landscape
• 30.2. Rare Biomarkers Specimen Collection And Stabilization Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Rare Biomarkers Specimen Collection And Stabilization Market Other Major And Innovative Companies

• 31.1. Eurofins Scientific SE
• 31.2. Agilent Technologies Inc.
• 31.3. PerkinElmer Inc.
• 31.4. Illumina Inc.
• 31.5. Charles River Laboratories International Inc.
• 31.6. Bio-Rad Laboratories Inc.
• 31.7. Bruker Corporation
• 31.8. QIAGEN N.V.
• 31.9. Miltenyi Biotec GmbH
• 31.10. Natera Inc.
• 31.11. Promega Corporation
• 31.12. Myriad Genetics
• 31.13. Hamilton Company
• 31.14. OraSure Technologies Inc.
• 31.15. Fluidigm Corporation

32. Global Rare Biomarkers Specimen Collection And Stabilization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rare Biomarkers Specimen Collection And Stabilization Market

34. Recent Developments In The Rare Biomarkers Specimen Collection And Stabilization Market

35. Rare Biomarkers Specimen Collection And Stabilization Market High Potential Countries, Segments and Strategies

• 35.1 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Rare Biomarkers Specimen Collection And Stabilization Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer